(HURN) Huron Consulting - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US4474621020

Consulting, Software, Managed Services

EPS (Earnings per Share)

EPS (Earnings per Share) of HURN over the last years for every Quarter: "2020-12": 0.45, "2021-03": 0.35, "2021-06": 0.69, "2021-09": 0.78, "2021-12": 0.8, "2022-03": 0.49, "2022-06": 0.83, "2022-09": 1.01, "2022-12": 1.12, "2023-03": 0.87, "2023-06": 1.38, "2023-09": 1.39, "2023-12": 1.29, "2024-03": 1.23, "2024-06": 1.68, "2024-09": 1.68, "2024-12": 1.9, "2025-03": 1.68, "2025-06": 1.89, "2025-09": 2.1, "2025-12": 0,

Revenue

Revenue of HURN over the last years for every Quarter: 2020-12: 198.347, 2021-03: 203.213, 2021-06: 230.126, 2021-09: 224.007, 2021-12: 248.294, 2022-03: 260.048999, 2022-06: 273.325, 2022-09: 285.37, 2022-12: 313.711, 2023-03: 317.895, 2023-06: 346.759, 2023-09: 358.178, 2023-12: 339.228, 2024-03: 355.961, 2024-06: 371.654, 2024-09: 370.049, 2024-12: 388.421, 2025-03: 395.69, 2025-06: 402.505, 2025-09: 441.284, 2025-12: null,

Dividends

Currently no dividends paid
Risk via 5d forecast
Volatility 30.0%
Value at Risk 5%th 42.4%
Relative Tail Risk -14.08%
Reward TTM
Sharpe Ratio 0.91
Alpha 22.45
CAGR/Max DD 1.71
Character TTM
Hurst Exponent 0.470
Beta 0.732
Beta Downside 0.597
Drawdowns 3y
Max DD 21.46%
Mean DD 5.83%
Median DD 4.77%

Description: HURN Huron Consulting January 13, 2026

Huron Consulting Group Inc. (NASDAQ:HURN) delivers management consulting and managed-services solutions across three primary segments-Healthcare, Education, and Commercial-leveraging a portfolio that spans performance-improvement advisory, digital transformation (including ERP, EHR, AI/automation, and CRM), revenue-cycle outsourcing, and specialized software such as the Huron Research suite for research-administration compliance.

In FY 2023 the firm generated roughly $1.2 billion in revenue, with an operating margin near 13%, reflecting strong demand for its healthcare-value-based-care initiatives, while the education segment faces headwinds from declining enrollment and state-budget cuts. A key sector driver is the accelerating adoption of AI-enabled analytics, which is expanding consulting spend across all three verticals, and macro-economic trends such as rising federal healthcare outlays and corporate digital-transformation budgets continue to underpin growth opportunities.

For a deeper, data-driven assessment of HURN’s valuation dynamics, you may find it useful to explore the company’s profile on ValueRay.

Piotroski VR‑10 (Strict, 0-10) 9.0

Net Income: 108.4m TTM > 0 and > 6% of Revenue
FCF/TA: 0.12 > 0.02 and ΔFCF/TA 4.41 > 1.0
NWC/Revenue: 8.91% < 20% (prev 11.59%; Δ -2.68% < -1%)
CFO/TA 0.13 > 3% & CFO 206.6m > Net Income 108.4m
Net Debt (627.0m) to EBITDA (210.1m): 2.98 < 3
Current Ratio: 1.44 > 1.5 & < 3
Outstanding Shares: last quarter (17.8m) vs 12m ago -3.67% < -2%
Gross Margin: 31.58% > 18% (prev 0.32%; Δ 3126 % > 0.5%)
Asset Turnover: 113.3% > 50% (prev 108.1%; Δ 5.19% > 0%)
Interest Coverage Ratio: 5.83 > 6 (EBITDA TTM 210.1m / Interest Expense TTM 31.4m)

Altman Z'' 3.35

A: 0.09 (Total Current Assets 475.0m - Total Current Liabilities 330.1m) / Total Assets 1.54b
B: 0.39 (Retained Earnings 606.0m / Total Assets 1.54b)
C: 0.13 (EBIT TTM 182.9m / Avg Total Assets 1.44b)
D: 0.57 (Book Value of Equity 598.7m / Total Liabilities 1.04b)
Altman-Z'' Score: 3.35 = A

Beneish M -3.03

DSRI: 0.94 (Receivables 414.9m/391.5m, Revenue 1.63b/1.44b)
GMI: 1.00 (GM 31.58% / 31.51%)
AQI: 1.04 (AQ_t 0.66 / AQ_t-1 0.64)
SGI: 1.13 (Revenue 1.63b / 1.44b)
TATA: -0.06 (NI 108.4m - CFO 206.6m) / TA 1.54b)
Beneish M-Score: -3.03 = AA

ValueRay F-Score (Strict, 0-100) 76.16

1. Piotroski: 9.0pt
2. FCF Yield: 4.99%
3. FCF Margin: 11.77%
4. Debt/Equity: 1.30
5. Debt/Ebitda: 2.98
6. ROIC - WACC: 4.98%
7. RoE: 21.35%
8. Revenue Trend: 96.91%
9. EPS Trend: 29.88%

What is the price of HURN shares?

As of January 24, 2026, the stock is trading at USD 171.34 with a total of 107,472 shares traded.
Over the past week, the price has changed by -6.61%, over one month by -3.85%, over three months by +11.88% and over the past year by +36.06%.

Is HURN a buy, sell or hold?

Huron Consulting has received a consensus analysts rating of 4.80. Therefore, it is recommended to buy HURN.
  • Strong Buy: 4
  • Buy: 1
  • Hold: 0
  • Sell: 0
  • Strong Sell: 0

What are the forecasts/targets for the HURN price?

Issuer Target Up/Down from current
Wallstreet Target Price 215.5 25.8%
Analysts Target Price 215.5 25.8%
ValueRay Target Price 227.3 32.7%

HURN Fundamental Data Overview January 17, 2026

P/E Trailing = 31.0854
P/E Forward = 21.5517
P/S = 1.9839
P/B = 6.3401
P/EG = 1.5199
Revenue TTM = 1.63b USD
EBIT TTM = 182.9m USD
EBITDA TTM = 210.1m USD
Long Term Debt = 589.6m USD (from longTermDebt, last quarter)
Short Term Debt = 34.1m USD (from shortTermDebt, last quarter)
Debt = 650.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 627.0m USD (from netDebt column, last quarter)
Enterprise Value = 3.84b USD (3.21b + Debt 650.9m - CCE 23.9m)
Interest Coverage Ratio = 5.83 (Ebit TTM 182.9m / Interest Expense TTM 31.4m)
EV/FCF = 20.04x (Enterprise Value 3.84b / FCF TTM 191.5m)
FCF Yield = 4.99% (FCF TTM 191.5m / Enterprise Value 3.84b)
FCF Margin = 11.77% (FCF TTM 191.5m / Revenue TTM 1.63b)
Net Margin = 6.66% (Net Income TTM 108.4m / Revenue TTM 1.63b)
Gross Margin = 31.58% ((Revenue TTM 1.63b - Cost of Revenue TTM 1.11b) / Revenue TTM)
Gross Margin QoQ = 30.55% (prev 33.16%)
Tobins Q-Ratio = 2.49 (Enterprise Value 3.84b / Total Assets 1.54b)
Interest Expense / Debt = 1.69% (Interest Expense 11.0m / Debt 650.9m)
Taxrate = 28.67% (12.2m / 42.6m)
NOPAT = 130.4m (EBIT 182.9m * (1 - 28.67%))
Current Ratio = 1.44 (Total Current Assets 475.0m / Total Current Liabilities 330.1m)
Debt / Equity = 1.30 (Debt 650.9m / totalStockholderEquity, last quarter 499.8m)
Debt / EBITDA = 2.98 (Net Debt 627.0m / EBITDA 210.1m)
Debt / FCF = 3.27 (Net Debt 627.0m / FCF TTM 191.5m)
Total Stockholder Equity = 507.6m (last 4 quarters mean from totalStockholderEquity)
RoA = 7.54% (Net Income 108.4m / Total Assets 1.54b)
RoE = 21.35% (Net Income TTM 108.4m / Total Stockholder Equity 507.6m)
RoCE = 16.67% (EBIT 182.9m / Capital Employed (Equity 507.6m + L.T.Debt 589.6m))
RoIC = 12.34% (NOPAT 130.4m / Invested Capital 1.06b)
WACC = 7.36% (E(3.21b)/V(3.86b) * Re(8.61%) + D(650.9m)/V(3.86b) * Rd(1.69%) * (1-Tc(0.29)))
Discount Rate = 8.61% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.20%
[DCF Debug] Terminal Value 83.36% ; FCFF base≈157.4m ; Y1≈194.2m ; Y5≈330.7m
Fair Price DCF = 335.6 (EV 6.41b - Net Debt 627.0m = Equity 5.79b / Shares 17.2m; r=7.36% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 29.88 | EPS CAGR: -33.70% | SUE: -4.0 | # QB: 0
Revenue Correlation: 96.91 | Revenue CAGR: 16.57% | SUE: 1.95 | # QB: 1
EPS next Quarter (2026-03-31): EPS=1.82 | Chg30d=+0.005 | Revisions Net=+1 | Analysts=4
EPS next Year (2026-12-31): EPS=8.74 | Chg30d=+0.008 | Revisions Net=+1 | Growth EPS=+14.7% | Growth Revenue=+9.5%

Additional Sources for HURN Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle